Salesforce, Inc. — Wall Street Analyst Estimates & Price Targets

CRM

NYSETechnologySoftware - ApplicationCIK 0001108524salesforce.comAbout CRM

Last close · Oct 16, 2026240.70−6.04 (−2.45%)

Market cap$198.1B

7 firms' latest targets, last 90 days: median $275.00 ($225.00–$315.00), 14% above the last close.

Price and published targets

daily close, 12 months · each dot a target, a firm's latest darker

Each firm's latest target

last 90 days · 7 firms

Date	Firm	Target	Previous	Change	Vs price then	Vs price now
2026-09-17	D.A. Davidson	$225.00	$200.00	▲ 13%	-10%	-7%
2026-09-11	Stifel	$275.00	—	—	+11%	+14%
2026-09-11	UBS	$240.00	$260.00	▼ 8%	-3%	+0%
2026-09-02	Morgan Stanley	$315.00	—	—	+22%	+31%
2026-08-27	Monness, Crespi, Hardt	$266.00	$222.00	▲ 20%	+7%	+11%
2026-08-27	Oppenheimer	$275.00	$250.00	▲ 10%	+34%	+14%
2026-08-25	Deutsche Bank	$315.00	—	—	+51%	+31%

Consensus estimates

revenue and EPS by fiscal year · reported years marked

FY	Revenue	YoY	EPS	YoY	Revenue range	EPS range	Analysts
2024reported	$34.9B	+11%	$4.20	+1900%	est. $34.8B+0%	est. $8.20	29
2025reported	$37.9B	+9%	$6.36	+51%	est. $38.0B+0%	est. $10.03	33
2026reported	$41.5B	+10%	$7.80	+23%	est. $41.5B+0%	est. $11.78	36
2027	$46.3B	+11%	$16.75	+42%	$46.1B–$46.5B	$16.71–$17.05	36
2028	$50.9B	+10%	$16.07	-4%	$50.1B–$51.9B	$15.01–$17.89	37
2029	$55.8B	+10%	$18.54	+15%	$53.9B–$57.7B	$16.25–$21.27	32
2030	$61.4B	+10%	$21.15	+14%	$60.6B–$62.2B	$20.78–$21.51	16
2031	$71.5B	+16%	$25.37	+20%	$70.5B–$72.4B	$24.92–$25.81	17

A reported year shows the company's figures, with the consensus beside it (revenue against it in %). Reported EPS is GAAP diluted; the analysts' EPS usually leaves items such as stock compensation out, so the two are not like for like. Faded: a year the valuation models do not read — they read the first 3, and a later one only while 10 or more analysts cover every year up to it — or one under 5 analysts.

The analysts at a glance

$275.00median target, 14% above the last close

Firms with a target · last 90 days: 7
Lowest – highest target: $225.00 – $315.00
Current grades of 36 firms: positive / neutral / negative: 25 / 10 / 1
Upgrades / downgrades · 12 months: 2 / 2
Consensus revenue growth · next 3 FY: +10% a year

Current grades

each firm's latest · 36 firms

As of	Firm	Grade
2026-10-12	Bank of America	“Buy”
2026-09-18	Citizens	“Market Outperform”
2026-09-18	Stephens & Co.	“Equal Weight”
2026-09-18	Wells Fargo	“Equal Weight”
2026-09-17	Citigroup	“Neutral”
2026-09-17	Stifel	“Buy”
2026-09-17	Guggenheim	“Buy”
2026-09-17	Canaccord Genuity	“Buy”
2026-09-17	BMO Capital	“Outperform”
2026-09-17	RBC Capital	“Sector Perform”

26 more

2026-09-17	Freedom Capital Markets	“Buy”
2026-09-17	Cantor Fitzgerald	“Overweight”
2026-09-16	Mizuho	“Outperform”
2026-09-02	BTIG	“Buy”
2026-09-02	Needham	“Buy”
2026-09-01	TD Cowen	“Buy”
2026-08-31	Argus Research	“Buy”
2026-08-27	J.P. Morgan	“Overweight”
2026-08-27	Barclays	“Overweight”
2026-08-27	Bernstein	“Underperform”
2026-08-27	Oppenheimer	“Outperform”
2026-08-27	UBS	“Neutral”
2026-08-27	Macquarie	“Neutral”
2026-08-27	D.A. Davidson	“Neutral”
2026-08-27	Jefferies	“Buy”
2026-08-27	Evercore ISI	“Outperform”
2026-08-27	Truist	“Buy”
2026-08-27	Morgan Stanley	“Equal Weight”
2026-07-09	Keybanc	“Sector Weight”
2026-05-28	Piper Sandler	“Overweight”
2026-05-28	Wedbush	“Outperform”
2026-05-28	B. Riley	“Buy”
2026-03-10	Northland Capital Markets	“Market Perform”
2026-02-26	Roth Capital	“Buy”
2025-12-04	Baird	“Outperform”
2025-12-04	Deutsche Bank	“Buy”

Grade changes

last 24 months · 11

Date	Firm	Grade
2026-10-12	Bank of America	“Underperform” → “Buy” upgrade
2026-07-21	Morgan Stanley	“Overweight” → “Equal Weight” downgrade
2026-07-09	Keybanc	“Overweight” → “Sector Weight” downgrade
2026-07-01	Guggenheim	“Neutral” → “Buy” upgrade
2025-08-15	D.A. Davidson	“Underperform” → “Neutral” upgrade
2025-05-29	RBC Capital	“Outperform” → “Sector Perform” downgrade
2025-04-21	Guggenheim	“Sell” → “Neutral” upgrade
2025-04-21	D.A. Davidson	“Neutral” → “Underperform” downgrade
2025-01-17	TD Cowen	“Hold” → “Buy” upgrade
2025-01-06	Guggenheim	“Neutral” → “Sell” downgrade
2024-11-19	Erste Group	“Hold” → “Buy” upgrade

49 older than 24 months

2024-10-02	Northland Capital Markets	“Market Perform” → “Outperform” upgrade
2024-09-24	Piper Sandler	“Neutral” → “Overweight” upgrade
2024-09-11	Erste Group	“Buy” → “Hold” downgrade
2024-08-30	Phillip Securities	“Buy” → “Accumulate” revised
2024-01-11	Baird	“Neutral” → “Outperform” upgrade
2023-12-21	Morgan Stanley	“Equal Weight” → “Overweight” upgrade
2023-12-20	Wells Fargo	“Overweight” → “Equal Weight” downgrade
2023-12-18	Wolfe Research	“Peer Perform” → “Outperform” upgrade
2023-10-23	Piper Sandler	“Overweight” → “Neutral” downgrade
2023-07-31	Morgan Stanley	“Overweight” → “Equal Weight” downgrade
2023-06-01	Societe Generale	“Buy” → “Hold” downgrade
2023-05-22	JMP Securities	“Market Perform” → “Perform” revised
2023-03-02	Needham	“Hold” → “Buy” upgrade
2023-02-06	JMP Securities	“Market Outperform” → “Outperform” revised
2023-01-20	TD Cowen	“Outperform” → “Market Perform” downgrade
2023-01-13	Atlantic Equities	“Overweight” → “Neutral” downgrade
2023-01-11	Bernstein	“Market Perform” → “Underperform” downgrade
2022-12-08	Baird	“Outperform” → “Neutral” downgrade
2022-12-02	Wolfe Research	“Outperform” → “Peer Perform” downgrade
2022-11-17	Monness, Crespi, Hardt	“Buy” → “Neutral” downgrade
2022-10-17	Northland Capital Markets	“Market Perform” → “Perform” revised
2022-09-28	Cleveland Research	“Buy” → “Neutral” downgrade
2022-09-02	Guggenheim	“Sell” → “Neutral” upgrade
2022-05-18	Roth Capital	“Neutral” → “Buy” upgrade
2022-01-05	UBS	“Buy” → “Neutral” downgrade
2021-09-24	Piper Sandler	“Neutral” → “Overweight” upgrade
2021-05-19	Morgan Stanley	“Equal Weight” → “Overweight” upgrade
2021-01-25	Loop Capital	“Sell” → “Hold” upgrade
2021-01-11	Piper Sandler	“Overweight” → “Neutral” downgrade
2020-12-02	Citigroup	“Buy” → “Neutral” downgrade
2020-11-12	Morgan Stanley	“Overweight” → “Equal Weight” downgrade
2020-02-28	CFRA	“Buy” → “Strong Buy” upgrade
2020-01-06	RBC Capital	“Outperform” → “Top Pick” upgrade
2019-01-07	Pivotal Research	“Hold” → “Buy” upgrade
2018-05-05	Argus	“Hold” → “Buy” upgrade
2018-05-03	Bernstein	“Underperform” → “Market Perform” upgrade
2018-02-15	Jefferies	“Hold” → “Buy” upgrade
2017-11-22	Roth Capital	“Buy” → “Neutral” downgrade
2017-01-12	Pivotal Research	“Buy” → “Hold” downgrade
2016-11-15	OTR Global	“Mixed” → “Positive” upgrade
2016-08-15	OTR Global	“Positive” → “Mixed” downgrade
2016-02-10	CLSA	“Outperform” → “Buy” revised
2015-12-18	Wedbush	“Neutral” → “Outperform” upgrade
2015-08-28	BNP Paribas Exane	“Neutral” → “Outperform” upgrade
2015-08-21	Pivotal Research	“Hold” → “Buy” upgrade
2015-07-07	Brean Capital	“Hold” → “Buy” upgrade
2015-05-21	Argus Research	“Hold” → “Buy” upgrade
2015-05-21	JMP Securities	“Market Outperform” → “Outperform” revised
2015-04-30	CLSA	“Buy” → “Outperform” revised

Targets, grades and estimates are quoted from third parties (via Financial Modeling Prep) and are theirs, not ours; each target links to the report it was published in. A firm counts once, at its latest target or grade.